Bank Julius Baer & Co. Ltd Zurich cut its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,286,094 shares of the conglomerate’s stock after selling 13,465 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Danaher were worth $294,638,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in DHR. Viking Global Investors LP raised its stake in shares of Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after purchasing an additional 2,216,789 shares during the period. Generation Investment Management LLP boosted its holdings in shares of Danaher by 34.0% during the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Danaher by 211.7% during the third quarter. Ameriprise Financial Inc. now owns 2,088,089 shares of the conglomerate’s stock worth $414,038,000 after purchasing an additional 1,418,243 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Danaher by 33.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 3,519,013 shares of the conglomerate’s stock worth $697,680,000 after purchasing an additional 891,210 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Danaher
In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.80% of the stock is owned by company insiders.
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.88 EPS. As a group, analysts predict that Danaher Corporation will post 8.43 EPS for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on DHR. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Argus reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research report on Friday, April 17th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $240.70.
Check Out Our Latest Research Report on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
